{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:07:01Z","timestamp":1793210821658,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research (CA)","doi-asserted-by":"publisher","award":["GSD-113375"],"award-info":[{"award-number":["GSD-113375"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer (US)","doi-asserted-by":"publisher","award":["WS1954106"],"award-info":[{"award-number":["WS1954106"]}],"id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Microbiome"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s40168-016-0156-3","type":"journal-article","created":{"date-parts":[[2016,2,27]],"date-time":"2016-02-27T04:21:28Z","timestamp":1456546888000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":120,"title":["Bloom and bust: intestinal microbiota dynamics in response to hospital exposures and Clostridium difficile colonization or infection"],"prefix":"10.1186","volume":"4","author":[{"given":"Caroline","family":"Vincent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thaddeus J.","family":"Edens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudeep","family":"Mehrotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Dewar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amee R.","family":"Manges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,14]]},"reference":[{"issue":"9","key":"156_CR1","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJMoa1408913","volume":"372","author":"FC Lessa","year":"2015","unstructured":"Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015;372(9):825\u201334. doi: 10.1056\/NEJMoa1408913 .","journal-title":"N Engl J Med"},{"issue":"4","key":"156_CR2","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/ajg.2013.4","volume":"108","author":"CM Surawicz","year":"2013","unstructured":"Surawicz CM, Brandt LJ, Binion DG, Ananthakrishnan AN, Curry SR, Gilligan PH, et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol. 2013;108(4):478\u201398. doi: 10.1038\/ajg.2013.4 . quiz 99.","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 6","key":"156_CR3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1469-0691.2006.01580.x","volume":"12","author":"EJ Kuijper","year":"2006","unstructured":"Kuijper EJ, Coignard B, Tull P. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect. 2006;12 Suppl 6:2\u201318. doi: 10.1111\/j.1469-0691.2006.01580.x .","journal-title":"Clin Microbiol Infect."},{"issue":"18","key":"156_CR4","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1056\/NEJMra0707500","volume":"359","author":"CP Kelly","year":"2008","unstructured":"Kelly CP, LaMont JT. Clostridium difficile\u2014more difficult than ever. N Engl J Med. 2008;359(18):1932\u201340. doi: 10.1056\/NEJMra0707500 .","journal-title":"N Engl J Med"},{"issue":"1","key":"156_CR5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nrgastro.2010.190","volume":"8","author":"AN Ananthakrishnan","year":"2011","unstructured":"Ananthakrishnan AN. Clostridium difficile infection: epidemiology, risk factors and management. Nat Rev Gastroenterol Hepatol. 2011;8(1):17\u201326. doi: 10.1038\/nrgastro.2010.190 .","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"156_CR6","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1086\/521859","volume":"46","author":"RC Owens Jr","year":"2008","unstructured":"Owens Jr RC, Donskey CJ, Gaynes RP, Loo VG, Muto CA. Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis. 2008;46 Suppl 1:S19\u201331. doi: 10.1086\/521859 .","journal-title":"Clin Infect Dis."},{"issue":"9","key":"156_CR7","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1086\/496986","volume":"41","author":"J Pepin","year":"2005","unstructured":"Pepin J, Saheb N, Coulombe MA, Alary ME, Corriveau MP, Authier S, et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis. 2005;41(9):1254\u201360. doi: 10.1086\/496986 .","journal-title":"Clin Infect Dis"},{"issue":"10","key":"156_CR8","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1007\/s10096-012-1603-0","volume":"31","author":"I Vesteinsdottir","year":"2012","unstructured":"Vesteinsdottir I, Gudlaugsdottir S, Einarsdottir R, Kalaitzakis E, Sigurdardottir O, Bjornsson ES. Risk factors for Clostridium difficile toxin-positive diarrhea: a population-based prospective case-control study. Eur J Clin Microbiol Infect Dis. 2012;31(10):2601\u201310. doi: 10.1007\/s10096-012-1603-0 .","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"8","key":"156_CR9","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1086\/521854","volume":"45","author":"MM Riggs","year":"2007","unstructured":"Riggs MM, Sethi AK, Zabarsky TF, Eckstein EC, Jump RL, Donskey CJ. Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin Infect Dis. 2007;45(8):992\u20138. doi: 10.1086\/521854 .","journal-title":"Clin Infect Dis"},{"issue":"13","key":"156_CR10","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJMoa1216064","volume":"369","author":"DW Eyre","year":"2013","unstructured":"Eyre DW, Cule ML, Wilson DJ, Griffiths D, Vaughan A, O\u2019Connor L, et al. Diverse sources of C. difficile infection identified on whole-genome sequencing. N Engl J Med. 2013;369(13):1195\u2013205. doi: 10.1056\/NEJMoa1216064 .","journal-title":"N Engl J Med"},{"issue":"9103","key":"156_CR11","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0140-6736(97)08062-8","volume":"351","author":"JK Shim","year":"1998","unstructured":"Shim JK, Johnson S, Samore MH, Bliss DZ, Gerding DN. Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea. Lancet. 1998;351(9103):633\u20136. doi: 10.1016\/S0140-6736(97)08062-8 .","journal-title":"Lancet"},{"issue":"3","key":"156_CR12","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/ajg.2015.22","volume":"110","author":"IM Zacharioudakis","year":"2015","unstructured":"Zacharioudakis IM, Zervou FN, Pliakos EE, Ziakas PD, Mylonakis E. Colonization with toxinogenic C. difficile upon hospital admission, and risk of infection: a systematic review and meta-analysis. Am J Gastroenterol. 2015;110(3):381\u201390. doi: 10.1038\/ajg.2015.22 . quiz 91.","journal-title":"Am J Gastroenterol"},{"issue":"18","key":"156_CR13","first-page":"1","volume":"1","author":"C Vincent","year":"2013","unstructured":"Vincent C, Stephens DA, Loo VG, Edens TJ, Behr MA, Dewar K, et al. Reductions in intestinal Clostridiales precede the development of nosocomial Clostridium difficile infection. Microbiome. 2013;1(18):1\u201311.","journal-title":"Microbiome"},{"issue":"7533","key":"156_CR14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nature13828","volume":"517","author":"CG Buffie","year":"2015","unstructured":"Buffie CG, Bucci V, Stein RR, McKenney PT, Ling L, Gobourne A, et al. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature. 2015;517(7533):205\u20138. doi: 10.1038\/nature13828 .","journal-title":"Nature"},{"issue":"17","key":"156_CR15","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1001\/jama.2015.3725","volume":"313","author":"DN Gerding","year":"2015","unstructured":"Gerding DN, Meyer T, Lee C, Cohen SH, Murthy UK, Poirier A, et al. Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C difficile infection: a randomized clinical trial. JAMA. 2015;313(17):1719\u201327. doi: 10.1001\/jama.2015.3725 .","journal-title":"JAMA"},{"key":"156_CR16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/pathogens3010014","volume":"3","author":"P Gu\u00e9rard","year":"2014","unstructured":"Gu\u00e9rard P. Metabolism of cholesterol and bile acids by the gut microbiota. Pathogens. 2014;3:14\u201324.","journal-title":"Pathogens"},{"key":"156_CR17","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/2049-2618-2-42","volume":"2","author":"CT Seto","year":"2014","unstructured":"Seto CT, Jeraldo P, Orenstein R, Chia N, DiBaise JK. Prolonged use of a proton pump inhibitor reduces microbial diversity: implications for Clostridium difficile susceptibility. Microbiome. 2014;2:42. doi: 10.1186\/2049-2618-2-42 .","journal-title":"Microbiome."},{"issue":"26","key":"156_CR18","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1056\/NEJM200012283432604","volume":"343","author":"CJ Donskey","year":"2000","unstructured":"Donskey CJ, Chowdhry TK, Hecker MT, Hoyen CK, Hanrahan JA, Hujer AM, et al. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med. 2000;343(26):1925\u201332. doi: 10.1056\/NEJM200012283432604 .","journal-title":"N Engl J Med"},{"issue":"2","key":"156_CR19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1473-3099(01)00066-4","volume":"1","author":"A Sullivan","year":"2001","unstructured":"Sullivan A, Edlund C, Nord CE. Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect Dis. 2001;1(2):101\u201314. doi: 10.1016\/S1473-3099(01)00066-4 .","journal-title":"Lancet Infect Dis"},{"key":"156_CR20","author":"DE Freedberg","year":"2015","unstructured":"Freedberg DE, Toussaint NC, Chen SP, Ratner AJ, Whittier S, Wang TC, et al. Proton pump inhibitors alter specific taxa in the human gastrointestinal microbiome: a crossover trial. Gastroenterology. 2015. doi: 10.1053\/j.gastro.2015.06.043 .","journal-title":"Gastroenterology"},{"issue":"6141","key":"156_CR21","doi-asserted-by":"crossref","first-page":"1237439","DOI":"10.1126\/science.1237439","volume":"341","author":"JJ Faith","year":"2013","unstructured":"Faith JJ, Guruge JL, Charbonneau M, Subramanian S, Seedorf H, Goodman AL, et al. The long-term stability of the human gut microbiota. Science. 2013;341(6141):1237439. doi: 10.1126\/science.1237439 .","journal-title":"Science"},{"issue":"7","key":"156_CR22","doi-asserted-by":"crossref","first-page":"e23035","DOI":"10.1371\/journal.pone.0023035","volume":"6","author":"J Jalanka-Tuovinen","year":"2011","unstructured":"Jalanka-Tuovinen J, Salonen A, Nikkila J, Immonen O, Kekkonen R, Lahti L, et al. Intestinal microbiota in healthy adults: temporal analysis reveals individual and common core and relation to intestinal symptoms. PLoS One. 2011;6(7):e23035. doi: 10.1371\/journal.pone.0023035 .","journal-title":"PLoS One"},{"key":"156_CR23","doi-asserted-by":"crossref","first-page":"246203","DOI":"10.1155\/2015\/246203","volume":"2015","author":"C Vincent","year":"2015","unstructured":"Vincent C, Mehrotra S, Loo VG, Dewar K, Manges AR. Excretion of host DNA in feces is associated with risk of Clostridium difficile infection. J Immunol Res. 2015;2015:246203. doi: 10.1155\/2015\/246203 .","journal-title":"J Immunol Res."},{"key":"156_CR24","volume-title":"The Microviridae. The Bacteriophages","author":"BA Fane","year":"2011","unstructured":"Fane BA, Brentlinger KL, Burch AD, Chen M, Hafenstein S, Moore E, et al. The Microviridae. The Bacteriophages. 2nd ed. Oxford: Oxford University Press; 2011.","edition":"2"},{"issue":"Suppl 2","key":"156_CR25","doi-asserted-by":"crossref","first-page":"S206","DOI":"10.1086\/516247","volume":"25","author":"DN Gerding","year":"1997","unstructured":"Gerding DN. Is there a relationship between vancomycin-resistant enterococcal infection and Clostridium difficile infection? Clin Infect Dis. 1997;25 Suppl 2:S206\u201310.","journal-title":"Clin Infect Dis."},{"issue":"12","key":"156_CR26","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1172\/JCI43918","volume":"120","author":"C Ubeda","year":"2010","unstructured":"Ubeda C, Taur Y, Jenq RR, Equinda MJ, Son T, Samstein M, et al. Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J Clin Invest. 2010;120(12):4332\u201341. doi: 10.1172\/JCI43918 .","journal-title":"J Clin Invest"},{"key":"156_CR27","unstructured":"Canadian Agency for Drugs and Technologies in Health. Proton pump inhibitors and C. difficile: a review of the clinical evidence. 2014.\u00a0 https:\/\/www.cadth.ca\/sites\/default\/files\/pdf\/htis\/dec-2014\/RC0582%20PPIs%20and%20C%20Difficile%20Final.pdf ."},{"issue":"7","key":"156_CR28","doi-asserted-by":"crossref","first-page":"G474","DOI":"10.1152\/ajpgi.00375.2012","volume":"305","author":"MY Wulp van der","year":"2013","unstructured":"van der Wulp MY, Derrien M, Stellaard F, Wolters H, Kleerebezem M, Dekker J, et al. Laxative treatment with polyethylene glycol decreases microbial primary bile salt dehydroxylation and lipid metabolism in the intestine of rats. Am J Physiol Gastrointest Liver Physiol. 2013;305(7):G474\u201382. doi: 10.1152\/ajpgi.00375.2012 .","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"7","key":"156_CR29","doi-asserted-by":"crossref","first-page":"e101344","DOI":"10.1371\/journal.pone.0101344","volume":"9","author":"AE Budding","year":"2014","unstructured":"Budding AE, Grasman ME, Eck A, Bogaards JA, Vandenbroucke-Grauls CM, van Bodegraven AA, et al. Rectal swabs for analysis of the intestinal microbiota. PLoS One. 2014;9(7):e101344. doi: 10.1371\/journal.pone.0101344 .","journal-title":"PLoS One"},{"issue":"7","key":"156_CR30","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1128\/JCM.31.7.1870-1875.1993","volume":"31","author":"CR Clabots","year":"1993","unstructured":"Clabots CR, Johnson S, Bettin KM, Mathie PA, Mulligan ME, Schaberg DR, et al. Development of a rapid and efficient restriction endonuclease analysis typing system for Clostridium difficile and correlation with other typing systems. J Clin Microbiol. 1993;31(7):1870\u20135.","journal-title":"J Clin Microbiol"},{"issue":"6","key":"156_CR31","doi-asserted-by":"crossref","first-page":"pdb prot5448","DOI":"10.1101\/pdb.prot5448","volume":"2010","author":"M Meyer","year":"2010","unstructured":"Meyer M, Kircher M. Illumina sequencing library preparation for highly multiplexed target capture and sequencing. Cold Spring Harb Protoc. 2010;2010(6):pdb prot5448. doi: 10.1101\/pdb.prot5448 .","journal-title":"Cold Spring Harb Protoc"},{"key":"156_CR32","unstructured":"BMTagger.\u00a0 ftp:\/\/ftp.ncbi.nlm.nih.gov\/pub\/agarwala\/bmtagger\/ ."},{"key":"156_CR33","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/1471-2105-11-187","volume":"11","author":"B Niu","year":"2010","unstructured":"Niu B, Fu L, Sun S, Li W. Artificial and natural duplicates in pyrosequencing reads of metagenomic data. BMC Bioinformatics. 2010;11:187. doi: 10.1186\/1471-2105-11-187 .","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"156_CR34","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14806\/ej.17.1.200","volume":"17","author":"M Martin","year":"2011","unstructured":"Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J. 2011;17(1):10\u20132.","journal-title":"EMBnet J"},{"key":"156_CR35","unstructured":"Jumpstart Consortium Human Microbiome Project Data Generation Working Group. 16S 454 sequencing protocol. 2010. http:\/\/hmpdacc.org\/doc\/16S_Sequencing_SOP_4.2.2.pdf ."},{"issue":"10","key":"156_CR36","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/nmeth.3589","volume":"12","author":"DT Truong","year":"2015","unstructured":"Truong DT, Franzosa EA, Tickle TL, Scholz M, Weingart G, Pasolli E, et al. MetaPhlAn2 for enhanced metagenomic taxonomic profiling. Nat Methods. 2015;12(10):902\u20133. doi: 10.1038\/nmeth.3589 .","journal-title":"Nat Methods"},{"issue":"6","key":"156_CR37","doi-asserted-by":"crossref","first-page":"e1002358","DOI":"10.1371\/journal.pcbi.1002358","volume":"8","author":"S Abubucker","year":"2012","unstructured":"Abubucker S, Segata N, Goll J, Schubert AM, Izard J, Cantarel BL, et al. Metabolic reconstruction for metagenomic data and its application to the human microbiome. PLoS Comput Biol. 2012;8(6):e1002358. doi: 10.1371\/journal.pcbi.1002358 .","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"156_CR38","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/bioinformatics\/btr595","volume":"28","author":"Y Zhao","year":"2012","unstructured":"Zhao Y, Tang H, Ye Y. RAPSearch2: a fast and memory-efficient protein similarity search tool for next-generation sequencing data. Bioinformatics. 2012;28(1):125\u20136. doi: 10.1093\/bioinformatics\/btr595 .","journal-title":"Bioinformatics"},{"issue":"1","key":"156_CR39","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27\u201330.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"156_CR40","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1128\/AAC.48.11.4427-4429.2004","volume":"48","author":"BP Currie","year":"2004","unstructured":"Currie BP, Lemos-Filho L. Evidence for biliary excretion of vancomycin into stool during intravenous therapy: potential implications for rectal colonization with vancomycin-resistant enterococci. Antimicrob Agents Chemother. 2004;48(11):4427\u20139. doi: 10.1128\/AAC.48.11.4427-4429.2004 .","journal-title":"Antimicrob Agents Chemother"},{"key":"156_CR41","unstructured":"The R project for statistical computing. http:\/\/www.r-project.org\/ ."}],"container-title":["Microbiome"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40168-016-0156-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T04:55:14Z","timestamp":1600232114000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.microbiomejournal.com\/content\/4\/1\/12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,14]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["156"],"URL":"https:\/\/doi.org\/10.1186\/s40168-016-0156-3","relation":{},"ISSN":["2049-2618"],"issn-type":[{"value":"2049-2618","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,14]]},"article-number":"12"}}